Trial Profile
Efficacy and Safety of Prescription Omega-3 Fatty Acid Added to Stable Statin Therapy in Patients With Type 2 Diabetes and Hypertriglyceridemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Omega-3-acid ethyl esters (Primary) ; HMG-CoA reductase inhibitors
- Indications Hypertriglyceridaemia; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Kuhnil Pharmaceutical Company
- 08 Dec 2014 New trial record